Mapping the genetic landscape across 14 psychiatric disorders
University of Colorado Boulder · Amsterdam Neuroscience · +324 more institutions
Abstract
Psychiatric disorders display high levels of comorbidity and genetic overlap1,2, challenging current diagnostic boundaries. For disorders for which diagnostic separation has been most debated, such as schizophrenia and bipolar disorder3, genomic methods have revealed that the majority of genetic signal is shared4. While over a hundred pleiotropic loci have been identified by recent cross-disorder analyses5, the full scope of shared and disorder-specific genetic influences remains poorly defined. Here we addressed this gap by triangulating across a suite of cutting-edge statistical and functional genomic analyses applied to 14 childhood- and adult-onset psychiatric disorders (1,056,201 cases). Using genetic…
Citation impact
- FWCI
- 60.49
- Percentile
- 100%
- References
- 76
Authors
458- ADAndrew D. GrotzingerCorresponding
University of Colorado Boulder
- JWJosefin Werme
Amsterdam Neuroscience, Vrije Universiteit Amsterdam
- WJWouter J. Peyrot
Amsterdam Neuroscience, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam
- OFOleksandr Frei
Oslo University Hospital, University of Oslo
- CDChristiaan de Leeuw
Amsterdam Neuroscience, Vrije Universiteit Amsterdam
Topics & keywords
- Schizophrenia (object-oriented programming)
- Psychiatric genetics
- Bipolar disorder
- Comorbidity
- Psychosis
- Anxiety
- Genetic association
- Genetic correlation
Funding
- ASAutism Speaks
- NANational Alliance for Research on Schizophrenia and DepressionAward: U01MH125050
- RPRegeneron Pharmaceuticals
- NINational Institute for Health and Care ResearchAwards: IS-BRC-1215-20018, IS-BRC-1215, BRC-1215-20018
- ECEuropean CommissionAwards: 965381, 101057385, 834057, 964874
- LLundbeckfondenAwards: R344-2020-1060, R155-2014-1724, R01MH124839, R01MH125938, R102-A9118, R248-2017-2003
- NNNovo NordiskAward: NNF21SA0072102
- NFNorges ForskningsrådAward: 334920
- NNNovo Nordisk FondenAwards: NNF21SA0072102, NNF20OC0065561
- HLH. Lundbeck A/SAwards: R102-A9118, R155-2014-1724, R248-2017-2003
- NINational Institutes of HealthAwards: R01GM148494, R01NS105746, R01MH106595, R01MH120219, R01DA054869, R01MH125938, P2CHD042849, R01MH124851, R01MH123922, R01MH104964, R01MH124847, R01MH119243, T32IR5226, R01NS102371, R01MH121521, P50AA022537, R01AG073593, K01DA051759, R01MH123451, U54GM115516, P30AG066614, MH124873, MH109532, MH124871
- CFCenter for Individualized Medicine, Mayo Clinic
- HEHORIZON EUROPE Framework ProgrammeAwards: 965381, 101057385, 964874
- CICanadian Institutes of Health Research
- NINational Institute of Mental HealthAwards: R01MH116037, K08MH135343, P2CHD042849, U01MH135970, MH109514, 1R01MH130899, R01MH106595, P30AG066614, R01MH123775, U24MH068457, R01MH120219, MH109532, R01MH104964, R21MH123908, R01MH125938, MH109528, MH085520, R01MH131685, 1R01NS128535, R01MH121924, R01MH136149, R01MH124851, 1R01MH124851-01, R01MH121521, R01MH123922, R01MH124839, U01AR076092, U01MH125050, MH124873, R01MH123451, R01MH112904